Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical study assessing suppressive effects following oral administration of of leuprolide on gonadotropins and gonadal steroids, as well as leuprolide levels compared to those seen after a single im depot injection of leuprolide

Next Previous
Search
Trial Profile

A clinical study assessing suppressive effects following oral administration of of leuprolide on gonadotropins and gonadal steroids, as well as leuprolide levels compared to those seen after a single im depot injection of leuprolide

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 21 Jun 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Leuprorelin (Primary) ; Leuprorelin
  • Indications Endometriosis
  • Focus Pharmacodynamics

    • Most Recent Events

    • 21 Jun 2022 New trial record
    • 13 Jun 2022 According to Enteris Biopharma Media Release, In addition to live presentation at the ENDO meeting on Monday June 13th, the full poster presentations will also be available in the virtual format starting on June 11, at 10:00 a.m. ET. Information about ENDO 2022 may be accessed at https://endo2022.endocrine.org/Home.
    • 13 Jun 2022 According to Enteris Biopharma Media Release, data from this trial published in ENDO 2022

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top